Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Phase II Trial Of Adjuvant Chemotherapy For Urothelial Carcinoma Comparing GC To Dose-Dense MVAC

NCT01639521 is registered in ClinicalTrials.gov with University of Southern California as lead sponsor.

NCT NCT01639521
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01639521 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Phase II Trial Of Adjuvant Chemotherapy For Urothelial Carcinoma Comparing GC To Dose-Dense MVAC
Lead sponsor
University of Southern California
Phase
Phase 2
Overall status
Withdrawn
Start date
May 31, 2013
Completion date
May 31, 2013
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

anterior urethral cancer, localized transitional cell cancer of the renal pelvis and ureter, posterior urethral cancer, recurrent bladder cancer, recurrent urethral cancer, regional transitional cell cancer of the renal pelvis and ureter, stage iii bladder cancer, transitional cell carcinoma of the bladder, ureter cancer, urethral cancer associated with invasive bladder cancer